Načítá se...
Ranolazine for stable angina pectoris
BACKGROUND: Stable angina pectoris is a chronic medical condition with significant impact on mortality and quality of life; it can be macrovascular or microvascular in origin. Ranolazine is a second‐line anti‐anginal drug approved for use in people with stable angina. However, the effects of ranolaz...
Uloženo v:
| Vydáno v: | Cochrane Database Syst Rev |
|---|---|
| Hlavní autoři: | , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
John Wiley & Sons, Ltd
2017
|
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6373632/ https://ncbi.nlm.nih.gov/pubmed/28178363 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/14651858.CD011747.pub2 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|